Context Therapeutics Inc Financial Flexibility Index
Context Therapeutics Inc financial flexibility index. Context Therapeutics Inc (CNTX) has a Financial Flexibility Index of -0.88x as of June 2026. Free cash flow of $-7.00 Million (operating CF $-7.02 Million minus capex $18.49K) represents -1% of total liabilities ($7.96 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Context Therapeutics Inc (2016–2025)
Financial flexibility index of Context Therapeutics Inc from 2016 to 2025. Historical Financial Flexibility Index trend for Context Therapeutics Inc across 9 annual periods. Check CNTX operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Context Therapeutics Inc Financial Flexibility Index by Year (2016–2025)
Context Therapeutics Inc financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Context Therapeutics Inc. For the full cash flow conversion analysis, see CNTX operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.29x | $-26.35 Million | $-26.39 Million | $8.02 Million | ▼ -4776.0% |
| 2024 | 0.07x | $201.00K | $-14.56 Million | $2.86 Million | ▲ +101.4% |
| 2023 | -5.02x | $-21.05 Million | $-21.05 Million | $4.19 Million | ▼ -23.8% |
| 2022 | -4.06x | $-13.01 Million | $-13.55 Million | $3.21 Million | ▼ -43.9% |
| 2021 | -2.82x | $-8.55 Million | $-8.80 Million | $3.03 Million | ▼ -4636.8% |
| 2020 | -0.06x | $-1.03 Million | $-1.03 Million | $17.39 Million | ▲ +49.2% |
| 2019 | -0.12x | $-2.84 Million | $-2.84 Million | $24.23 Million | ▲ +95.1% |
| 2017 | -2.38x | $-22.32 Million | $-22.35 Million | $9.38 Million | ▲ +15.2% |
| 2016 | -2.80x | $-30.54 Million | $-30.57 Million | $10.89 Million | — |